PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity
Open Access
- 29 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Biomedical Science
- Vol. 28 (1), 1-19
- https://doi.org/10.1186/s12929-021-00720-y
Abstract
Obesity-related cardiovascular risk, end points, and mortality are strongly related to arterial stiffening. Current therapeutic approaches for arterial stiffening are not focused on direct targeting within the vessel. Perivascular adipose tissue (PVAT) surrounding the artery has been shown to modulate vascular function and inflammation. Peroxisome proliferator-activated receptor γ (PPARγ) activation significantly decreases arterial stiffness and inflammation in diabetic patients with coronary artery disease. Thus, we hypothesized that PPARγ activation alters the PVAT microenvironment, thereby creating a favorable environment for the attenuation of arterial stiffening in obesity. Obese ob/ob mice were used to investigate the effect of PPARγ activation on the attenuation of arterial stiffening. Various cell types, including macrophages, fibroblasts, adipocytes, and vascular smooth muscle cells, were used to test the inhibitory effect of pioglitazone, a PPARγ agonist, on the expression of elastolytic enzymes. PPARγ activation by pioglitazone effectively attenuated arterial stiffening in ob/ob mice. This beneficial effect was not associated with the repartitioning of fat from or changes in the browning of the PVAT depot but was strongly related to improvement of the PVAT microenvironment, as evidenced by reduction in the expression of pro-inflammatory and pro-oxidative factors. Pioglitazone treatment attenuated obesity-induced elastin fiber fragmentation and elastolytic activity and ameliorated the obesity-induced upregulation of cathepsin S and metalloproteinase 12, predominantly in the PVAT. In vitro, pioglitazone downregulated Ctss and Mmp12 in macrophages, fibroblasts, and adipocytes—cell types residing within the adventitia and PVAT. Ultimately, several PPARγ binding sites were found in Ctss and Mmp12 in Raw 264.7 and 3T3-L1 cells, suggesting a direct regulatory mechanism by which PPARγ activation repressed the expression of Ctss and Mmp-12 in macrophages and fibroblasts. PPARγ activation attenuated obesity-induced arterial stiffening and reduced the inflammatory and oxidative status of PVAT. The improvement of the PVAT microenvironment further contributed to the amelioration of elastin fiber fragmentation, elastolytic activity, and upregulated expression of Ctss and Mmp12. Our data highlight the PVAT microenvironment as an important target against arterial stiffening in obesity and provide a novel strategy for the potential clinical use of PPARγ agonists as a therapeutic against arterial stiffness through modulation of PVAT function.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST-107-2320-B-006-063MY3, MOST-107-2320-B-006-003)
- National Health Research Institutes (NHRI-EX107-10511SI)
This publication has 50 references indexed in Scilit:
- Evidence for contemporary arterial stiffening in obese children and adolescents using pulse wave velocity: A systematic review and meta-analysisAtherosclerosis, 2015
- Joint scientific statement of the European Association for the Study of Obesity and the European Society of HypertensionJournal of Hypertension, 2015
- Effect of Weight Loss on Pulse Wave VelocityArteriosclerosis, Thrombosis, and Vascular Biology, 2015
- Proinflammatory Phenotype of Perivascular AdipocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in AdultsJournal of the American College of Cardiology, 2014
- Increased Aortic Stiffness and Attenuated Lysyl Oxidase Activity in ObesityArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver diseaseJournal of the American Society of Hypertension, 2012
- Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocityJournal of Hypertension, 2012
- Arterial Destiffening With Atorvastatin in Overweight and Obese Middle-Aged and Older AdultsHypertension, 2009
- Obesity is associated with increased arterial stiffness from adolescence until old ageJournal of Hypertension, 2005